Talha Badar, MBBS, MD

Mayo Clinic

Latest Content

1. Expert panel discussing managing fatigue and phlebotomy burden in pulmonary embolism patients using Rusteride at OncUpdates conference.

PV at ASH 2025

01/10/2026

Ep. 4: Managing Fatigue and Phlebotomy Burden in PV With Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

Managing Hematocrit and Symptoms in PV: Dose Titration Strategies for Rusfertide.

PV at ASH 2025

01/08/2026

Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

1. A group of medical researchers and doctors discussing cancer treatment algorithms in a professional conference setting.

PV at ASH 2025

01/06/2026

Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

1. Innovative hematocrit control approaches in polycythemia vera presented by leading oncology experts for improved patient management.

PV at ASH 2025

01/02/2026

Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD

Polycythemia Vera management insights, hematocrit control, and clinical treatment strategies by Dr. Andrew Kuykendall, Dr. Aaron Gerds, Dr. Talha Badar, Dr. Rohit Gosain, and Dr. Rahul Gosain.

PV at ASH 2025

12/22/2025

Clinical Insights: VERIFY Trial Shows Rusfertide’s Potential to Transform PV Treatment (Full Video)

Talha Badar, MBBS, MDAaron Gerds, MDAndrew Kuykendall, MDRahul Gosain, MD, MBARohit Gosain, MD